A randomized phase II study of disitamab vedotin (DV) plus toripalimab and chemotherapy versus DV plus toripalimab versus chemotherapy as perioperative treatment for HER2-expressing locally advanced gastric or gastroesophageal junction adenocarcinoma (GC/GEJ)

被引：0

作者：

Li, Z. ^{[1
]}

Ji, J. ^{[1
]}

Bu, Z. ^{[1
]}

Wang, Y. ^{[1
]}

Wu, Z. ^{[1
]}

Nie, P. ^{[2
]}

Li, W-L. ^{[3
]}

Li, C. ^{[4
]}

You, J. ^{[5
]}

Hu, W. ^{[6
]}

Zhang, Y. ^{[7
]}

Chen, L. ^{[8
]}

Zhao, P. ^{[9
]}

Li, G. ^{[10
]}

Li, Y. ^{[11
]}

Zhuang, J. ^{[12
]}

Shen, J. ^{[13
]}

Feng, D. ^{[14
]}

Fang, J. ^{[15
]}

机构：

[1] Beijing Canc Hosp, Gastrointestinal Tumor Ctr Ward, Beijing, Peoples R China

[2] Gansu Wuwei Tumour Hosp, Dept Gastrointestinal Surg, Wuwei, Peoples R China

[3] Yunnan Canc Hosp, Gastr & Small Bowel Surg, Kunming, Yunnan, Peoples R China

[4] Shandong Tumour Hosp, Dept Gastroenterol, Jinan, Peoples R China

[5] Xiamen Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, Xiamen, Peoples R China

[6] Changzhi Peoples Hosp, Dept Gastrointestinal Surg, Changzhi, Peoples R China

[7] Harbin Med Univ Canc Hosp, Dept Gastroenterol, Haerbin, Peoples R China

[8] Fujian Canc Hosp, Dept Gastrointestinal Surg, Fuzhou, Peoples R China

[9] Sichuan Canc Hosp, Dept Gastrointestinal Surg, Chengdu, Peoples R China

[10] Southern Med Univ, Nanfang Hosp, Gen Surg, Guangzhou, Peoples R China

[11] Guangdong Gen Hosp, Dept Gastrointestinal Surg, Guangzhou, Peoples R China

[12] Henan Canc Hosp, Gen Surg, Zhengzhou, Peoples R China

[13] RemeGen Co Ltd, Med Oncol, Yantai, Peoples R China

[14] RemeGen Co Ltd, Biostat, Yantai, Peoples R China

[15] Tongji Univ, Sch Life Sci & Technol, Shanghai, Peoples R China

来源：

ANNALS OF ONCOLOGY | 2024年 / 35卷

关键词：

D O I：

10.1016/j.annonc.2024.08.1540

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1474TiP

引用

页码：S911 / S911

页数：1